How Big Is the Dementia Drug Market | Growth Analysis & Forecast 2031

Q: What is the market size of the dementia drug market in 2025 and 2031?

The dementia drug market was valued at USD 13.5 billion in 2024 and is anticipated to exceed USD 23 billion by 2031

Q: What is the CAGR of the dementia drug market between 2025 and 2031?

The dementia drug market is anticipated to grow at a CAGR of 7.1% during the forecast period.

Q: What are the key trends in the dementia drug market?

Key trends include the rise of disease-modifying treatments, use of AI in drug development, precision medicine, and early intervention through biomarkers.

Q: What are the main drivers of the dementia drug market?

The dementia drug market is driven by aging demographics, increasing prevalence of dementia, growing research investments, and supportive government healthcare policies.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5967

Publication Date: Jul 2025

What is the Dementia drug Market Size?

According to 6Wresearch internal database and industry insights, the Dementia drug market was valued at USD 13.5 billion in 2024 and is anticipated to exceed USD 23 billion by 2031, registering a steady at a CAGR of 7.1% during the forecast period.

This market is witnessing robust growth fuelled by an aging global population, increased awareness of neurodegenerative disorders, and a rising prevalence of Alzheimer’s disease and related conditions. Demand is also being driven by the growing focus on early diagnosis and treatment, government support for dementia care initiatives, and increasing R&D investment in novel drug development. The emergence of disease-modifying therapies and innovations in precision medicine are further contributing to market expansion.

Major Growth Factors of the Dementia drug Market

Rising geriatric population globally
Increasing prevalence of Alzheimer’s and other dementias
Advancements in drug discovery and neurotherapeutics
Government initiatives for dementia care and awareness
Growing R&D investments by pharmaceutical companies
Development of disease-modifying drugs
Expansion of early diagnosis and screening programs
Rising healthcare expenditure in emerging economies

Dementia drug Market Trends

The dementia drug market is witnessing a change in trends towards the development of disease-modifying therapies aimed at altering the progression of dementia rather than just alleviating symptoms. There is increasing adoption of biomarker-based diagnosis and personalized treatment strategies. Collaboration between biotech firms and research institutes is intensifying, and the use of AI in drug discovery is accelerating pipeline development.

Emerging Developments in the Dementia drug Market

The dementia drug market is seeing the emergence of new classes of drugs such as monoclonal antibodies, with several receiving fast-track regulatory approvals. Companies are investing heavily in early-stage research, clinical trials, and the use of digital technologies to improve diagnosis and treatment outcomes. Strategic alliances between pharma giants and health-tech companies are enabling innovation in drug delivery and patient monitoring.